Most patients with infectious illness have certain symptoms and signs that are indicative of a disease but becomes difficult to identify the actual causing agent. These set of signs and symptoms are referred to as syndrome.
This report contains market size and forecasts of Syndromic Multiplex Diagnostic in Global, including the following market information:
Global Syndromic Multiplex Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Syndromic Multiplex Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gastrointestinal Syndromic Multiplex Diagnostic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Syndromic Multiplex Diagnostic include Abbott, Hologic, Bosch, Danaher, Johnson & Johnson, Danaher, Bio-Rad Laboratories, Luminex and bioMérieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Syndromic Multiplex Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Syndromic Multiplex Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Syndromic Multiplex Diagnostic Market Segment Percentages, by Type, 2021 (%)
Gastrointestinal Syndromic Multiplex Diagnostic
Central Nervous System Syndromic Multiplex Diagnostic
Others
Global Syndromic Multiplex Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Syndromic Multiplex Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostics Laboratories
Research Institutes
Others
Global Syndromic Multiplex Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Syndromic Multiplex Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Syndromic Multiplex Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Syndromic Multiplex Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Hologic
Bosch
Danaher
Johnson & Johnson
Danaher
Bio-Rad Laboratories
Luminex
bioMérieux
Qiagen
Alveo Technologies
Mesa Biotech
Applied BioCode
Akonni Biosystems
Diagenode Diagnostics